ChAdOx1.HIVconsv62 trials for HIV

All ChAdOx1.HIVconsv62 trials · All HIV trials

Phase breakdown

Recruiting trials studying ChAdOx1.HIVconsv62 for HIV

• Combination Vaccination and Broadly Neutralising Antibody Therapy in HIV
  NCT07054931 · Phase: Phase 2 · Ages: 18 Years to 64 Years · Sex: All (male and female) · 3 locations
• Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in Adults Initiated on ART During Acute HIV-1
  NCT06071767 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 12 locations
• RV630 - Approach to Control HIV With Immune Enhancement and Vaccination (ACHIEV
  NCT06484335 · Phase: Phase 1 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location

Common questions

How many trials study ChAdOx1.HIVconsv62 for HIV?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.